In the latest draft guidance, USFDA tried to tackle a major loophole called #39;citizen petitions#39; used by branded drug makers or innovators to delay the entry of generic drugsfrom Moneycontrol Business News https://ift.tt/2RmXOTk
Tuesday, October 2, 2018
US drug regulator issues guidance to tackle delays speed-up generic approvals
In the latest draft guidance, USFDA tried to tackle a major loophole called #39;citizen petitions#39; used by branded drug makers or innovators to delay the entry of generic drugsfrom Moneycontrol Business News https://ift.tt/2RmXOTk
No comments:
Post a Comment